Basal Cell Carcinoma - Epidemiology Forecast to 2027

Basal Cell Carcinoma - Epidemiology Forecast to 2027

Category

Pharmaceuticals

Published Date

1st Feb 2018

Pages

50

Choose License

Final Price

DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Basal Cell Carcinoma (Basal Cell Epithelioma) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Basal Cell Carcinoma (Basal Cell Epithelioma) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Basal Cell Carcinoma (Basal Cell Epithelioma) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma) outlook. It also includes the explanation of changing trends of epidemiology outlining the Basal Cell Carcinoma (Basal Cell Epithelioma) scenario.

Basal Cell Carcinoma (Basal Cell Epithelioma) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Basal Cell Carcinoma (Basal Cell Epithelioma) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Basal Cell Carcinoma (Basal Cell Epithelioma) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Basal Cell Carcinoma (Basal Cell Epithelioma) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Basal Cell Carcinoma (Basal Cell Epithelioma)

Key assessments
• Patient Segmentation in Basal Cell Carcinoma (Basal Cell Epithelioma)
• Basal Cell Carcinoma (Basal Cell Epithelioma) Risk & Burden
• Factors driving growth in a specific Basal Cell Carcinoma (Basal Cell Epithelioma) patient population
1. Report Introduction
2. Basal Cell Carcinoma (Basal Cell Epithelioma) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Basal Cell Carcinoma (Basal Cell Epithelioma) in 2017
2.2. Patient Share Distribution of Basal Cell Carcinoma (Basal Cell Epithelioma) in 2027
3. Disease Background and Overview: Basal Cell Carcinoma (Basal Cell Epithelioma)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Basal Cell Carcinoma (Basal Cell Epithelioma) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Basal Cell Carcinoma (Basal Cell Epithelioma) in 7MM – By Countries
5. Epidemiology of Basal Cell Carcinoma (Basal Cell Epithelioma) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.1.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.1.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.1.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.4.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.4.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.4.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.5.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.5.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.5.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.6.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.6.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.6.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.7.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.7.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.7.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.8.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.8.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.8.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.9.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.9.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.9.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
6. Unmet Needs of the Basal Cell Carcinoma (Basal Cell Epithelioma)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in 7MM
Table 2: Total Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2027)*
Table 5: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2027)*
Table 6: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2027)
Table 7: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2027)
Table 8: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2027) *
Table 9: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2027) *
Table 10: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2027)
Table 11: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2027)
Table 12: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2027) *
Table 13: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2027) *
Table 14: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2027)
Table 15: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2027)
Table 16: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2027) *
Table 17: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2027) *
Table 18: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2027)
Table 19: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2027)
Table 20: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2027) *
Table 21: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2027) *
Table 22: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2027)
Table 23: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2027)
Table 24: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2027) *
Table 25: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2027) *
Table 26: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2027)
Table 27: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2027)
Table 28: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2027) *
Table 29: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2027) *
Table 30: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2027)

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us